Arlene Morris is an experienced board member and executive with a strong focus on biopharmaceuticals and animal welfare. Currently serving as a board member at Edgewise Therapeutics and Charleston Animal Society, Arlene has held various leadership roles across multiple organizations, including CEO of Willow Advisors, LLC, and board member positions at Cogent Biosciences, Viridian Therapeutics, Palatin Technologies, and Viveve, Inc., among others. Arlene's contributions include leadership in compensation and audit committees, showcasing extensive expertise in governance and strategic oversight within the healthcare and research sectors. Additionally, Arlene served as a board member for the MUSC Foundation for Research and Development and held a trustee position at Carlow University, indicating a commitment to both community and academic advancement.
This person is not in the org chart
This person is not in any teams